Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention and Treatment of Differentiation Syndrome in APL
NCT04446806Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ruxolitinib in differentiation syndrome (DS), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
03
Conditions
differentiation syndrome (DS)
Beyond the preview
Go deeper on NCT04446806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446806.